United States — Net Sales
Edwards Lifesciences United States — Net Sales increased by 3.4% to $937.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.8%, from $838.90M to $937.60M. Over 4 years (FY 2021 to FY 2025), United States — Net Sales shows an upward trend with a 4.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing market share or higher demand for structural heart products in the US, while a decrease may signal competitive pressure or market saturation.
Detailed definition
This metric represents the total revenue generated from the sale of medical devices and structural heart technologies wi...
Peer comparison
Peers in the medical device sector typically report geographic revenue splits, allowing for direct comparison of domestic versus international growth rates.
ew_segment_united_states_net_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $795.70M | $753.30M | $739.40M | $749.50M | $800.80M | $786.80M | $795.50M | $849.10M | $895.30M | $869.90M | $894.40M | $940.70M | $816.90M | $804.60M | $643.80M | $838.90M | $889.70M | $907.50M | $907.00M | $937.60M |
| QoQ Change | — | -5.3% | -1.8% | +1.4% | +6.8% | -1.7% | +1.1% | +6.7% | +5.4% | -2.8% | +2.8% | +5.2% | -13.2% | -1.5% | -20.0% | +30.3% | +6.1% | +2.0% | -0.1% | +3.4% |
| YoY Change | — | — | — | — | +0.6% | +4.4% | +7.6% | +13.3% | +11.8% | +10.6% | +12.4% | +10.8% | -8.8% | -7.5% | -28.0% | -10.8% | +8.9% | +12.8% | +40.9% | +11.8% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's united states — net sales?
- Edwards Lifesciences (EW) reported united states — net sales of $937.60M in Q1 2026.
- How has Edwards Lifesciences's united states — net sales changed year-over-year?
- Edwards Lifesciences's united states — net sales increased by 11.8% year-over-year, from $838.90M to $937.60M.
- What is the long-term trend for Edwards Lifesciences's united states — net sales?
- Over 4 years (2021 to 2025), Edwards Lifesciences's united states — net sales has grown at a 4.6% compound annual growth rate (CAGR), from $2.96B to $3.54B.
- What does united states — net sales mean?
- Total revenue earned from customers located in the United States.